Key Takeaways
- Thermo Fisher Scientific shares jumped Thursday after the medical device maker reported better-than-expected fourth-quarter results.
- Sales and profit increased year-over-year and topped Visible Alpha estimates.
- Sales rose across all four of the company’s divisions.
Shares of Thermo Fisher Scientific (TMO) rose Thursday after the medical device maker’s fourth-quarter results topped analysts’ estimates.
Thermo Fisher reported revenue of $11.4 billion, up about 5% year-over-year and better than the $11.28 billion Visible Alpha consensus. Profit narrowly beat estimates at $1.83 billion, or $4.78 per share, up from $4.20 a year ago. Adjusted earnings per share (EPS) of $6.10 also topped expectations.
Sales increased across all four of the company’s divisions, with revenue at its largest segment, Laboratory Products and Biopharma Services, rising 4%. Last quarter, shares fell as sales were flat or declined in two segments.
Thermo Fisher shares were up 6.6% intraday after entering Thursday roughly flat over the prior 12 months.
:max_bytes(150000):strip_icc()/GettyImages-1439393558-2818d0bcda934f18a7d56327139d8b3d.jpg?w=1200&resize=1200,0&ssl=1&description=Thermo+Fisher+Stock+Surges+as+Medical+Device+Maker%E2%80%99s+Results+Top+Estimates){kind=link}